Literature DB >> 10623377

Willingness to pay and the valuation of programmes for the prevention and control of influenza.

S Birch1, A Gafni, B O'Brien.   

Abstract

In this paper, we consider the role of willingness to pay (WTP) as a method for measuring the impact of healthcare programmes on population well-being. Alternative methods of outcome valuation, such as quality-adjusted life-years (QALYs), measure values through individuals' willingness to trade off a particular commodity, future life. Moreover, the method of valuation fails to incorporate several dimensions of benefit relevant to measuring well-being that are particularly important in programmes aimed at the prevention and control of influenza. In contrast, WTP provides a broad method of valuation based on individuals' willingness to trade off a much wider range of commodities. In addition, WTP incorporates externalities and uncertainty within individual valuations. We show that the main limitations of the WTP approach are not avoided by adoption of the QALY approach.

Mesh:

Year:  1999        PMID: 10623377     DOI: 10.2165/00019053-199916001-00008

Source DB:  PubMed          Journal:  Pharmacoeconomics        ISSN: 1170-7690            Impact factor:   4.981


  18 in total

1.  The distribution problem in economic evaluation: income and the valuation of costs and consequences of health care programmes.

Authors:  Cam Donaldson; Stephen Birch; Amiram Gafni
Journal:  Health Econ       Date:  2002-01       Impact factor: 3.046

2.  Willingness to pay in the context of an economic evaluation of healthcare programs: theory and practice.

Authors:  A Gafni
Journal:  Am J Manag Care       Date:  1997-05       Impact factor: 2.229

Review 3.  Implications of basing health-care resource allocations on cost-utility analysis in the presence of externalities.

Authors:  R J Labelle; J E Hurley
Journal:  J Health Econ       Date:  1992-10       Impact factor: 3.883

4.  Labor market valuations of life and limb: empirical evidence and policy implications.

Authors:  W K Viscusi
Journal:  Public Policy       Date:  1978

5.  Willingness-to-pay as a measure of benefits. Relevant questions in the context of public decisionmaking about health care programs.

Authors:  A Gafni
Journal:  Med Care       Date:  1991-12       Impact factor: 2.983

Review 6.  An exercise on the feasibility of carrying out secondary economic analyses.

Authors:  T Jefferson; M Mugford; A Gray; V Demicheli
Journal:  Health Econ       Date:  1996 Mar-Apr       Impact factor: 3.046

Review 7.  When do the "dollars" make sense? Toward a conceptual framework for contingent valuation studies in health care.

Authors:  B O'Brien; A Gafni
Journal:  Med Decis Making       Date:  1996 Jul-Sep       Impact factor: 2.583

8.  Willingness to pay for antenatal carrier screening for cystic fibrosis.

Authors:  C Donaldson; P Shackley; M Abdalla; Z Miedzybrodzka
Journal:  Health Econ       Date:  1995 Nov-Dec       Impact factor: 3.046

9.  The counterrevolution in health care financing.

Authors:  V R Fuchs
Journal:  N Engl J Med       Date:  1987-04-30       Impact factor: 91.245

10.  What do patients value? Willingness to pay for ultrasound in normal pregnancy.

Authors:  D M Berwick; M C Weinstein
Journal:  Med Care       Date:  1985-07       Impact factor: 2.983

View more
  5 in total

Review 1.  Pharmacoeconomics of influenza vaccination in the elderly: reviewing the available evidence.

Authors:  M J Postma; R M Baltussen; M L Heijnen; L T de Berg; J C Jager
Journal:  Drugs Aging       Date:  2000-09       Impact factor: 3.923

2.  A generic simulation model to manage a vaccination program.

Authors:  Arben Asllani; Lawrence Ettkin
Journal:  J Med Syst       Date:  2010-01-29       Impact factor: 4.460

Review 3.  Insulin lispro: a pharmacoeconomic review of its use in diabetes mellitus.

Authors:  Christopher J Dunn; Greg L Plosker
Journal:  Pharmacoeconomics       Date:  2002       Impact factor: 4.981

4.  Economic evaluations of neuraminidase inhibitors to control influenza.

Authors:  Michaël Schwarzinger; Karine Lacombe; Fabrice Carrat
Journal:  Expert Rev Pharmacoecon Outcomes Res       Date:  2003-04       Impact factor: 2.217

5.  Cost-benefit analysis of influenza vaccination in a public healthcare unit.

Authors:  Giorgio L Colombo; Antonio Ferro; Marta Vinci; Maria Zordan; Giulio Serra
Journal:  Ther Clin Risk Manag       Date:  2006-06       Impact factor: 2.423

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.